07 Jan 2001

Cefavora® (Cefavora® Tropfen) - Deutschland

Cefavora® Description, Presentation and Dosage

Cefavora® Description

Cefavora® Drug Class Description


Cefavora® Drug Description

100 g enth.: Ginkgo biloba 'Urtink.' 1,3 g, Viscum album 'Urtink.' 2,7 g, Crataegus 'Urtink.' 7,5 g.

Cefavora® Generic Name

Cefavora® Tropfen

Cefavora® Presentation

Cefavora® Presentation


Cefavora® Manufacturer


Related Learning Zones

Hypogonadism Knowledge Centre

Hypogonadism Knowledge Centre

The Hypogonadism Knowledge Centre provides healthcare professionals with free access to disease awareness sections such as epidemiology, pathophysiology, signs and symptoms, treatment options to assist the process of diagnosis, treatment and monitoring of patients with the condition. The regularly updated publications digest area contains analysis and comment on recent scientific articles related to male hypogonadism.


Type 2 Diabetes Knowledge Centre and CME

Type 2 Diabetes Knowledge Centre and CME

The Type 2 Diabetes Learning Zone comprises the Type 2 Diabetes Mellitus Knowledge Centre containing current epidemiology statistics, current diagnosis criteria from WHO and ADA, treatment options and latest guidelines; a Therapy Focus area compiling material on emerging insulin/incretin treatment combinations; and two free CME activities, which are the EACCME-accredited ‘Role of Newer Therapies for Type 2 Diabetes in Combination with Insulin’ (worth 1 CME credit) and ‘Best Practice in Type 2 Diabetes: Update on Incretin Therapies in Combination with Insulin’. 

Cefavora® Dosage

Cefavora® Adult Dosage


Cefavora® Precautions, Reactions and Contraindications

Cefavora® Special Precautions

Related Drugs - Angiology

Back to top